Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
anabolic steroid
|
| gptkbp:administeredBy |
intramuscular injection
|
| gptkbp:brand |
gptkb:nandrolone_phenylpropionate
|
| gptkbp:chemicalClass |
nandrolone ester
|
| gptkbp:controlledSubstanceSchedule |
gptkb:United_Kingdom
gptkb:United_States |
| gptkbp:developedBy |
gptkb:Organon
|
| gptkbp:halfLife |
2-4 days
|
| https://www.w3.org/2000/01/rdf-schema#label |
Durabolin
|
| gptkbp:introducedIn |
1959
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:relatedTo |
gptkb:Deca-Durabolin
|
| gptkbp:sideEffect |
hair loss
acne liver toxicity gynecomastia |
| gptkbp:usedFor |
muscle growth
treatment of osteoporosis treatment of anemia |
| gptkbp:WADAStatus |
prohibited
|
| gptkbp:bfsParent |
gptkb:nandrolone
|
| gptkbp:bfsLayer |
8
|